Published in Women's Health Weekly, November 10th, 2005
"Remifentanil has been suggested as an ideal opioid for patient-controlled analgesia (PCA) in labor, but the safety profile has not been established. The aims of a preliminary prospective observational study" by scientists in England "were to investigate the maternal side-effects and early neonatal effects, and to assess the placental transfer of remifentanil PCA during labor."
"Women with no known obstetric complications or contraindication to remifentanil were recruited (n=50)," wrote I. Volikas and colleagues. "Remifentanil was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly